Invesco Ltd. Arvinas, Inc. Transaction History

Invesco Ltd.

$503 Billion
Q1 2025

A detailed history of Invesco Ltd. transactions in Arvinas, Inc. stock. As of the latest transaction made, Invesco Ltd. holds 81,747 shares of ARVN stock, worth $532,172. This represents 0.0% of its overall portfolio holdings.

Number of Shares

81,747

Previous 37,254 119.43%

Holding current value

$532,172

Previous $714,000 19.75%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 12, 2025	BUY	$7.02 - $20.5 $312,340 - $912,106	44,493 Added 119.43%	81,747 $573,000
Q4 2024 Feb 13, 2025	BUY	$17.83 - $28.04 $10,359 - $16,291	581 Added 1.58%	37,254 $714,000
Q3 2024 Nov 12, 2024	BUY	$23.66 - $32.73 $12,871 - $17,805	544 Added 1.51%	36,673 $903,000
Q2 2024 Aug 13, 2024	BUY	$24.46 - $40.4 $37,252 - $61,529	1,523 Added 4.4%	36,129 $961,000
Q1 2024 May 14, 2024	SELL	$36.38 - $52.31 $5.01 Million - $7.21 Million	-137,831 Reduced 79.93%	34,606 $1.43 Million
Q4 2023 Feb 12, 2024	BUY	$14.19 - $42.33 $1.8 Million - $5.37 Million	126,835 Added 278.13%	172,437 $7.1 Million
Q3 2023 Nov 13, 2023	SELL	$19.64 - $28.21 $2.81 Million - $4.04 Million	-143,232 Reduced 75.85%	45,602 $895,000
Q2 2023 Aug 11, 2023	SELL	$21.73 - $31.43 $876,110 - $1.27 Million	-40,318 Reduced 17.59%	188,834 $4.69 Million
Q1 2023 May 12, 2023	SELL	$26.15 - $37.26 $13.7 Million - $19.5 Million	-522,927 Reduced 69.53%	229,152 $6.26 Million
Q4 2022 Feb 13, 2023	SELL	$32.47 - $57.24 $416,979 - $735,076	-12,842 Reduced 1.68%	752,079 $25.7 Million
Q3 2022 Nov 14, 2022	BUY	$41.87 - $57.99 $8.54 Million - $11.8 Million	204,045 Added 36.38%	764,921 $34 Million
Q2 2022 Aug 15, 2022	SELL	$36.01 - $74.24 $1.93 Million - $3.99 Million	-53,722 Reduced 8.74%	560,876 $23.6 Million
Q1 2022 May 16, 2022	BUY	$60.27 - $81.57 $4.27 Million - $5.78 Million	70,801 Added 13.02%	614,598 $41.4 Million
Q4 2021 Feb 14, 2022	BUY	$65.85 - $96.21 $4.02 Million - $5.88 Million	61,087 Added 12.66%	543,797 $44.7 Million
Q3 2021 Nov 15, 2021	BUY	$73.2 - $107.87 $24.9 Million - $36.7 Million	340,242 Added 238.82%	482,710 $39.7 Million
Q2 2021 Aug 17, 2021	BUY	$60.45 - $84.26 $8.05 Million - $11.2 Million	133,146 Added 1428.3%	142,468 $11 Million
Q1 2021 May 17, 2021	SELL	$58.19 - $91.37 $7.32 Million - $11.5 Million	-125,832 Reduced 93.1%	9,322 $617,000
Q4 2020 Feb 16, 2021	BUY	$20.19 - $84.93 $2.73 Million - $11.5 Million	135,154 New	135,154 $11.5 Million
Q3 2020 Nov 16, 2020	SELL	$22.99 - $36.34 $395,841 - $625,702	-17,218 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$29.88 - $56.74 $2.57 Million - $4.89 Million	-86,174 Reduced 83.35%	17,218 $578,000
Q1 2020 May 15, 2020	BUY	$33.0 - $54.5 $881,793 - $1.46 Million	26,721 Added 34.85%	103,392 $4.17 Million
Q4 2019 Feb 14, 2020	BUY	$15.39 - $44.38 $1.18 Million - $3.4 Million	76,671 New	76,671 $3.15 Million

Others Institutions Holding ARVN

# of Institutions

246

Shares Held

62.5M

Call Options Held

2.65M

Put Options Held

1.1M

View Full List

About ARVINAS, INC.

Ticker ARVN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,205,300
Market Cap $346M
Description
Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...

More about ARVN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.

Account